PARP-1 modulation of mTOR signaling in response to a DNA alkylating agent

Chantal Ethier1, Maxime Tardif, Laura Arul

  • 1Cancer Axis, CHUQ Research Center and Faculty of Medicine, Laval University, Quebec City, Quebec, Canada.

Plos One
|October 31, 2012
PubMed

Insights

Poly(ADP-ribose) polymerase-1 (PARP-1) activation triggers necrotic cell death by altering cellular energy and inhibiting mTOR signaling. Antioxidants and PARP inhibitors block these PARP-1-mediated events.

Area of Science:

  • Cell Biology
  • Biochemistry
  • Molecular Biology

Background:

  • Poly(ADP-ribose) polymerase-1 (PARP-1) plays a crucial role in cellular responses to DNA damage, influencing cell death pathways like autophagy, apoptosis, and necrosis.
  • The specific cell death outcome following PARP activation is dependent on injury severity and cell type.

Purpose of the Study:

  • To investigate the molecular mechanisms by which PARP-1 activation leads to necrotic cell death in HEK293 cells exposed to N-methyl-N'-nitro-N'-nitrosoguanine (MNNG).
  • To elucidate the role of altered cellular energy levels and the mTOR signaling pathway in PARP-1-mediated necrosis.

Main Methods:

  • HEK293 cells were treated with MNNG, an alkylating agent, to induce PARP-1 activation.
  • Levels of NAD+, ATP, and AMP were measured to assess cellular energy status.
  • Activation of AMP-activated protein kinase (AMPK) and modulation of the mTORC1 and mTORC2 pathways were analyzed through specific protein phosphorylation.
  • The effects of PARP-1 inhibition (using AG14361) and antioxidant treatment (N-acetyl-L-cysteine, NAC) were evaluated.

Main Results:

  • MNNG exposure led to massive poly(ADP-ribose) (PAR) synthesis, decreased NAD+ and ATP, and increased AMP levels.
  • AMPK activation and mTORC1 inhibition (via Raptor phosphorylation) occurred, alongside decreased S6 phosphorylation.
  • Loss of Akt phosphorylation at Ser473 preceded cell death by necrosis.
  • Inhibition of PARP-1 or treatment with NAC abrogated all observed signaling events and prevented necrosis.

Conclusions:

  • PARP-1 activation and subsequent PAR synthesis significantly impact cellular energy homeostasis and inhibit mTORC1 signaling.
  • Modulation of the mTORC2 complex, evidenced by Rictor and Akt phosphorylation changes, is implicated in PARP-1-induced necrosis.
  • Reactive oxygen species (ROS) production is involved in PARP-1 activation and the subsequent modulation of mTOR signaling pathways.
  • PARP-1 and PAR play integral roles in orchestrating necrotic cell death through the intricate balance of cellular signaling pathways.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...